Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat schizophrenia, mixed/manic episodes, and bipolar maintenance; depression, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; attention-deficit hyperactivity disorders; obsessive-compulsive and panic disorders, and bulimia nervosa; and bipolar and treatment-resistant depression. Eli Lilly trades an average of 8.4 million shares per day with a market cap of $57 billion.
52 Week Range: $35.46 to $53.99
Book Value: $12.79
Price To Book: 4Earnings Payout Percentage: 54% The shares have moved higher 36% over the last 52 weeks. Analysts are calling for a price target of $50.36. A quick look at the chart displays the fact that "we did that, done that before" and the trend is your friend so far. I recommended Lilly a few months ago, and that worked out well. After the recent pullback in price, Eli Lilly is once again in the kill zone. Investors are receiving $1.96 in dividends for a yield of 3.8%. A very nice yield for a company demanding only 14 times earnings to buy a share. In the last month, the stock has really moved higher with a 11.6% increase. Since the start of the year, it appears the shares are up over 25%. Again, the pullback gives the stock a chance to breathe, and it may trade down near $50 a share due to the "round number" effect, but take that as a buying opportunity. Presently, based on the float ,the short interest is unimportant and not a worry. The small amount of short interest is 1.9%. I would keep an eye on this number after the election for clues in the market direction into 2013. LLY Dividend data by YCharts
JNJ data by YCharts
Johnson & Johnson (JNJ - Get Report) Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science -- bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. Our Family of Companies comprises: The world's sixth-largest consumer health company The world's largest and most diverse medical devices and diagnostics company The world's fifth-largest biologics company And the world's eighth-largest pharmaceuticals company We have more than 250 operating companies in 60 countries employing approximately 129,000 people. Our worldwide headquarters is in New Brunswick, New Jersey, USA. Johnson & Johnson trades an average of 11.1 million shares per day with a market cap of $196 billion.